Alves Costa Silva, Carolina http://orcid.org/0000-0003-1920-142X
Piccinno, Gianmarco http://orcid.org/0000-0003-1947-1817
Suissa, Déborah
Bourgin, Mélanie http://orcid.org/0000-0001-9867-6807
Schreibelt, Gerty http://orcid.org/0000-0002-0156-8365
Durand, Sylvère
Birebent, Roxanne
Fidelle, Marine http://orcid.org/0000-0002-5589-9688
Sow, Cissé
Aprahamian, Fanny
Manghi, Paolo http://orcid.org/0000-0003-0846-6529
Punčochář, Michal http://orcid.org/0000-0002-1915-9391
Asnicar, Francesco http://orcid.org/0000-0003-3732-1468
Pinto, Federica
Armanini, Federica
Terrisse, Safae
Routy, Bertrand http://orcid.org/0000-0003-1955-9149
Drubay, Damien http://orcid.org/0000-0002-9997-9727
Eggermont, Alexander M. M.
Kroemer, Guido
Segata, Nicola http://orcid.org/0000-0002-1583-5794
Zitvogel, Laurence http://orcid.org/0000-0003-1596-0998
Derosa, Lisa
Bol, Kalijn F.
de Vries, I. Jolanda M. http://orcid.org/0000-0002-8653-4040
Article History
Received: 9 May 2023
Accepted: 22 January 2024
First Online: 23 February 2024
Competing interests
: L.Zi. founded EverImmune and is the SAB president of EverImmune. L.ZI. had grant support from Daichi Sankyo, Kaleido, 9 meters and Pileje. A.M.M.E.: consulting fees from Acetra, Agenus, BioInvent, Brenus, CatalYm, Epics, Ellipses, Galecto, GenOway, IO Biotech, IQVIA, ISA Pharmaceuticals, Merck&Co, MSD, Pierre Fabre, Sairopa, Scorpion, Sellas, SkylineDX, TigeTx, Trained Immunity TX. A.M.M.E.: participation on a Data Safety Monitoring Board: Boehringer Ingelheim, BioNTech, and Pfizer. A.M.M.E.: lectures for BMS, MSD. A.M.M.E.: stock or stock options for IO Biotech, SkylineDx and Sairopa. G.K. has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys, and Vascage. G.K. is on the Board of Directors of the Bristol Myers Squibb Foundation France. G.K. is a scientific co-founder of EverImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. G.K. is in the scientific advisory boards of Hevolution, Institut Servier and Longevity Vision Funds. G.K. is the inventor of patents covering therapeutic targeting of aging, cancer, cystic fibrosis and metabolic disorders. G.K.’s brother, Romano Kroemer, was an employee of Sanofi and now consults for Boehringer-Ingelheim. B.R. is co-founder of Science Curebiota. L.D. is a SAB member of EverImmune. K.F.B.: consulting fees (institutional) from MSD and Pierre Fabre. The remaining authors declare no competing interests.